{{Rsnum
|rsid=3774968
|Gene=NFKB1
|Chromosome=4
|position=102609955
|Orientation=plus
|GMAF=0.3701
|Gene_s=NFKB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 12.3 | 40.0 | 47.7
| HCB | 15.6 | 62.2 | 22.2
| JPT | 29.5 | 45.5 | 25.0
| YRI | 1.6 | 22.2 | 76.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 15.6 | 62.2 | 22.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23757261
|Title=Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens
}}{{PMID Auto
|PMID=18990758
|Title=Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
|OA=1
}}